Nicobright Enorama (Nicotine Resinate)

Nicotine Resinate, the active ingredient in Nicobright Enorama, is a nicotine salt presented as an oral formulation for oral use. It is employed as a nicotine replacement to help individuals reduce dependence on tobacco and manage withdrawal symptoms during cessation attempts. The product is manufactured for the EU market and complies with relevant pharmaceutical standards.

GNH USA supplies Nicobright Enorama as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nicotine Resinate is used in nicotine replacement therapy to support individuals who are trying to quit smoking. - Smoking cessation: helps reduce nicotine cravings and withdrawal symptoms in adult smokers seeking to quit. - Harm reduction: provides a controlled nicotine source for smokers who cannot immediately stop tobacco use. - Research support: serves as a nicotine source in clinical studies evaluating nicotine dependence and related interventions.

Nicotine Resinate may cause a range of adverse reactions, most of which are dose‑related and reversible upon discontinuation.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient tension‑type headache. - Dizziness: occasional light‑headedness. - Insomnia: difficulty falling or staying asleep. - Irritation of the mouth or throat: mild local discomfort. - Increased heart rate: mild tachycardia.

Serious or Rare Side Effects: - Hypertension: elevated blood pressure requiring medical review. - Arrhythmia: irregular heart rhythm in susceptible individuals. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Persistent vomiting: may lead to dehydration. - Chest pain: could indicate cardiovascular strain. - Mood changes: anxiety or depression exacerbation.

When considering Nicotine Resinate, several safety measures should be observed. - Cardiovascular disease: use with caution in patients with hypertension, coronary artery disease, or arrhythmias. - Pregnancy: avoid unless clearly needed; discuss risks with a healthcare professional. - Breastfeeding: assess potential nicotine exposure to the infant before use. - Concomitant stimulant use: monitor for additive effects on heart rate and blood pressure. - Pediatric use: not recommended for children without specialist guidance. - Store at ambient temperature: keep below 25 °C, protect from moisture, and retain in the original container.

Nicotine Resinate can interact with other medications, altering their efficacy or safety profile.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may amplify hypertensive response. - Beta‑blockers: nicotine‑induced tachycardia may reduce therapeutic effect. - Anticoagulants: nicotine can affect platelet function, potentially increasing bleeding risk.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): monitor for increased anxiety or insomnia. - Antidiabetic agents: nicotine may affect glucose metabolism; adjust monitoring. - Caffeine‑containing products: combined stimulant effect may cause jitteriness.